Unlikely to cause harm — often a labeling or packaging issue.
Failed Dissolution Specification: During analysis of the 18 month long term stability testing, it was noticed that the drug release results at the 4 hour time point are not meeting specifications.
| Brand name | BUPROPION HYDROCHLORIDE |
| Generic name | BUPROPION HYDROCHLORIDE |
| Active ingredient(s) | BUPROPION HYDROCHLORIDE |
| Distributed by / for | Sun Pharmaceutical Industries Inc. Cranbury, NJ 08512 |
| NDC | 47335-738-86 |
| Full product label | buPROPion Hydrochloride Extended-¿release Tablets USP (SR), 200 mg, Twice-A-Day, Rx Only, 60 count Bottle, Distributed by: Sun Pharmaceutical Industries Inc. Cranbury, NJ 08512, Manufactured By: Sun Pharmaceutical Ind. Ltd., Halol Baroda Highway, Halol 389 350, Gujarat, India, NDC 47335-738-86 |
| Recalling firm | Sun Pharma Global Fze |
| Distribution | Nationwide and Puerto Rico |
| Quantity | 35,235 bottles |
| Recall initiated | 2015-07-17 |
| Report date | 2015-08-26 |
| Recall completed | 2016-03-22 |
| Recall number | D-1345-2015 |
| Classification | Class III |
| FDA status | Terminated |
| Origin on file | Sharm United Arab Emirates |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗